Stefan Jacobsson

1.4k total citations · 1 hit paper
25 papers, 1.0k citations indexed

About

Stefan Jacobsson is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Stefan Jacobsson has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 6 papers in Genetics and 4 papers in Surgery. Recurrent topics in Stefan Jacobsson's work include Platelet Disorders and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Stefan Jacobsson is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Stefan Jacobsson collaborates with scholars based in Sweden, Finland and Canada. Stefan Jacobsson's co-authors include Hans Wadenvik, Bob Olsson, Lena Carlsson, Per‐Ola Andersson, Margareta Jernås, Björn Carlsson, Krista Vaht, Christine Wennerås, Christina Welinder‐Olsson and Börje Ridell and has published in prestigious journals such as Nature Medicine, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Stefan Jacobsson

25 papers receiving 1.0k citations

Hit Papers

T-cell-mediated cytotoxicity toward platelets in chronic ... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers

Stefan Jacobsson
Armead H. Johnson United States
Helena Alves Portugal
Lesley M. Chapman United States
C L Christian United States
R. Or Israel
P Bird United Kingdom
Armead H. Johnson United States
Stefan Jacobsson
Citations per year, relative to Stefan Jacobsson Stefan Jacobsson (= 1×) peers Armead H. Johnson

Countries citing papers authored by Stefan Jacobsson

Since Specialization
Citations

This map shows the geographic impact of Stefan Jacobsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Jacobsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Jacobsson more than expected).

Fields of papers citing papers by Stefan Jacobsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Jacobsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Jacobsson. The network helps show where Stefan Jacobsson may publish in the future.

Co-authorship network of co-authors of Stefan Jacobsson

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Jacobsson. A scholar is included among the top collaborators of Stefan Jacobsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Jacobsson. Stefan Jacobsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jons, Daniel, et al.. (2016). Early hematopoiesis in multiple sclerosis patients. Journal of Neuroimmunology. 299. 158–163. 4 indexed citations
2.
Olsson, Bob, Margareta Jernås, Stefan Jacobsson, et al.. (2010). The autocrine motility factor receptor is overexpressed on the surface of B cells in Binet C chronic lymphocytic leukemia. Medical Oncology. 28(4). 1542–1548. 1 indexed citations
3.
Haglund, Caroline, Anna Åleskog, Lena Håkansson, et al.. (2010). The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing. Toxicology Letters. 194(3). 102–107. 16 indexed citations
4.
Olsson, Bob, et al.. (2010). BCR-ABL1 transcript levels increase in peripheral blood but not in granulocytes after physical exercise in patients with chronic myeloid leukemia. Scandinavian Journal of Clinical and Laboratory Investigation. 71(1). 7–11. 7 indexed citations
5.
Thörn, Ingrid, Erik Forestier, Britt Thuresson, et al.. (2009). Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population‐based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002–2006. European Journal Of Haematology. 84(2). 117–127. 7 indexed citations
6.
Björklund, Elisabet, Irma Matinlauri, Anne Tierens, et al.. (2009). Quality Control of Flow Cytometry Data Analysis for Evaluation of Minimal Residual Disease in Bone Marrow From Acute Leukemia Patients During Treatment. Journal of Pediatric Hematology/Oncology. 31(6). 406–415. 16 indexed citations
7.
Lönnerholm, Gudmar, Ingrid Thörn, Christer Sundström, et al.. (2008). In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia. Leukemia Research. 33(1). 46–53. 8 indexed citations
8.
Lewerin, Catharina, Stefan Jacobsson, Göran Lindstedt, & Herman Nilsson‐Ehle. (2008). Serum biomarkers for atrophic gastritis and antibodies againstHelicobacter pyloriin the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy. Scandinavian Journal of Gastroenterology. 43(9). 1050–1056. 34 indexed citations
9.
Junevik, Katarina, et al.. (2006). The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL). Annals of Hematology. 86(2). 89–94. 9 indexed citations
10.
Andersson, Per‐Ola, Stefan Jacobsson, Lena Carlsson, Hans Wadenvik, & Bob Olsson. (2004). Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura. Thrombosis and Haemostasis. 93(1). 139–144. 57 indexed citations
11.
Olsson, Bob, Per‐Ola Andersson, Margareta Jernås, et al.. (2003). T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nature Medicine. 9(9). 1123–1124. 519 indexed citations breakdown →
12.
Boman, Hans, Hans Hedelin, Stefan Jacobsson, & Sten Holmäng. (2002). Newly Diagnosed Bladder Cancer: The Relationship of Initial Symptoms, Degree of Microhematuria and Tumor Marker Status. The Journal of Urology. 168(5). 1955–1959. 32 indexed citations
13.
Boman, Hans, et al.. (2002). Newly Diagnosed Bladder Cancer:. The Journal of Urology. 1955–1959. 1 indexed citations
14.
Jacobsson, Stefan. (2001). The Clinical Value of Serum Transferrin Measurements.. PubMed. 13(2). 53–60. 1 indexed citations
15.
Jacobsson, Stefan, Hans Wadenvik, Jack Kutti, & Birgitta Swolin. (1999). Low Megakaryocyte Ploidy in Ph-Positive Chronic Myelogenous Leukemia Measured by Flow Cytometry. American Journal of Clinical Pathology. 111(2). 185–190. 3 indexed citations
18.
Jacobsson, Stefan, Jan Carneskog, Börje Ridell, et al.. (1996). Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis. European Journal Of Haematology. 56(5). 287–292. 15 indexed citations
20.
Wadenvik, Hans, Stefan Jacobsson, Jack Kutti, & Martti Syrjälä. (1987). In vitro and in vivo behavior of 111In‐labelled platelets: An experimental study of healthy male volunteers. European Journal Of Haematology. 38(5). 415–425. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026